ImageneBio (IMA) Enterprise Value (2020 - 2024)
Historic Enterprise Value for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to -$138.0 million.
- ImageneBio's Enterprise Value rose 2990.86% to -$138.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$138.0 million, marking a year-over-year increase of 2990.86%. This contributed to the annual value of -$175.5 million for FY2023, which is 1179.89% down from last year.
- Latest data reveals that ImageneBio reported Enterprise Value of -$138.0 million as of Q3 2024, which was up 2990.86% from -$145.4 million recorded in Q2 2024.
- In the past 5 years, ImageneBio's Enterprise Value registered a high of -$55.9 million during Q3 2020, and its lowest value of -$281.0 million during Q1 2021.
- Moreover, its 5-year median value for Enterprise Value was -$162.5 million (2020), whereas its average is -$169.6 million.
- Per our database at Business Quant, ImageneBio's Enterprise Value crashed by 34020.59% in 2021 and then skyrocketed by 3510.87% in 2023.
- ImageneBio's Enterprise Value (Quarter) stood at -$162.5 million in 2020, then tumbled by 42.91% to -$232.2 million in 2021, then skyrocketed by 32.41% to -$156.9 million in 2022, then decreased by 11.8% to -$175.5 million in 2023, then grew by 21.33% to -$138.0 million in 2024.
- Its Enterprise Value stands at -$138.0 million for Q3 2024, versus -$145.4 million for Q2 2024 and -$157.3 million for Q1 2024.